The presence of SGLTs (SGLT-1 and/or SGLT-2) have been confirmed in various types of cancer cells, such as, inter alia, hepatocellular carcinoma (HCC), pancreatic, prostate, bowel, lung and breast cancers, as well as brain, head and neck tumours [1,6,34,40,47,48,49,50,51,52]. Here, SLC5A1 is linked to cancer.